Koninklijke Philips NV vs Spotify Technology — how do they compare? Koninklijke Philips NV trades at $24.24 (market cap $23.52B), while Spotify Technology trades at $529.14 (market cap $108.22B). The key difference: Spotify Technology is far larger — about 4.6× Koninklijke Philips NV's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Spotify Technology pays none. Which is the better fit depends on your goals — on Pluang, investors hold Koninklijke Philips NV for 84 Days and Spotify Technology for 111 Days on average.
| PHG | SPOT | |
|---|---|---|
Market Cap | $23.52B | $108.22B |
Volume | 1,635,069 | 1,655,796 |
Sector | Health | Media |
52-Week High | $32.91 | $692.04 |
52-Week Low | $23.81 | $412.75 |
Typical Hold Time | 84 Days | 111 Days |
Enterprise Value | $29.87B | $98.23B |
Dividend Yield | 4.17% | — |
Signals from Pluang's Aura AI — not financial advice
PHG trades at $24.30, up 0.87% with a bearish technical signal despite three consecutive quarterly earnings beats. The company shows improving fundamentals with net income turning positive at $895 million in 2025 after previous losses, supported by strong operational cash flow of $1.17 billion. Recent developments include new product launches in healthcare technology and a $33.7 million ARPA-H award for AI-enabled stroke care.
While analyst consensus leans Hold (63.64%), the improving profitability trajectory and reasonable valuation (P/E 18.94) present opportunity, though technical weakness and competitive healthcare market risks require monitoring. The stock faces resistance near $25 with support at $24, with institutional ownership showing mixed signals through recent acquisitions.
Spotify (SPOT) trades at $526.42, up 2.63% with strong technical momentum. The stock shows robust fundamental improvement with revenue growing from $11.7B in 2022 to $17.2B in 2025, while net income turned positive reaching $2.2B. Recent earnings show mixed results with Q2 2026 missing expectations, but analyst sentiment remains overwhelmingly positive with 62% buy ratings and a $606.50 consensus target.
The outlook remains favorable with continued revenue growth and margin expansion driving profitability. Key risks include competitive pressures in streaming and execution challenges. With strong institutional support and improving cash flow generation, SPOT presents a compelling growth story, though investors should monitor Q3 2026 earnings due October 22 for confirmation of the positive trajectory.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.
Read more on SPOT →